305 related articles for article (PubMed ID: 26997226)
1. Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay.
Cunnion KM; Hair PS; Krishna NK; Whitley PH; Goldberg CL; Fadeyi EA; Maes LY
Transfusion; 2016 Jul; 56(7):1845-8. PubMed ID: 26997226
[TBL] [Abstract][Full Text] [Related]
2. Discriminating the hemolytic risk of blood type A plasmas using the complement hemolysis using human erythrocytes (CHUHE) assay.
Cunnion KM; Hair PS; Krishna NK; Sass MA; Enos CW; Whitley PH; Maes LY; Goldberg CL
Transfusion; 2017 Mar; 57(3):517-524. PubMed ID: 28000304
[TBL] [Abstract][Full Text] [Related]
3. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.
Weinstock C; Möhle R; Dorn C; Weisel K; Höchsmann B; Schrezenmeier H; Kanz L
Transfusion; 2015 Mar; 55(3):605-10. PubMed ID: 25251967
[TBL] [Abstract][Full Text] [Related]
4. The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction.
Roumenina LT; Bartolucci P; Pirenne F
Transfus Med Rev; 2019 Oct; 33(4):225-230. PubMed ID: 31672341
[TBL] [Abstract][Full Text] [Related]
5. Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats.
Kumar PS; Pallera HK; Hair PS; Rivera MG; Shah TA; Werner AL; Lattanzio FA; Cunnion KM; Krishna NK
Transfusion; 2016 Aug; 56(8):2133-45. PubMed ID: 27282513
[TBL] [Abstract][Full Text] [Related]
6. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.
Balbuena-Merle R; West FB; Tormey CA; Hendrickson JE
Transfusion; 2019 Jun; 59(6):1911-1915. PubMed ID: 30865314
[TBL] [Abstract][Full Text] [Related]
7. Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease and the Role of the Classical Complement Pathway: A Case Report.
Hair PS; Heck TP; Carr DT; Watson KD; Price J; Krishna NK; Cunnion KM; Owen WC
J Hematol; 2021 Feb; 10(1):18-21. PubMed ID: 33643505
[TBL] [Abstract][Full Text] [Related]
8. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
Gajewski JL; Petz LD; Calhoun L; O'Rourke S; Landaw EM; Lyddane NR; Hunt LA; Schiller GJ; Ho WG; Champlin RE
Blood; 1992 Jun; 79(11):3076-85. PubMed ID: 1586749
[TBL] [Abstract][Full Text] [Related]
9. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Josephson CD; Castillejo MI; Grima K; Hillyer CD
Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
[TBL] [Abstract][Full Text] [Related]
10. Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy.
Yazdanbakhsh K; Kang S; Tamasauskas D; Sung D; Scaradavou A
Blood; 2003 Jun; 101(12):5046-52. PubMed ID: 12576307
[TBL] [Abstract][Full Text] [Related]
11. Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.
Ibanez C; Habibi A; Mekontso-Dessap A; Chadebech P; Chami B; Bierling P; Galactéros F; Rieux C; Nataf J; Bartolucci P; Peyrard T; Pirenne F
Transfusion; 2016 Jul; 56(7):1828-33. PubMed ID: 27145018
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and mechanisms of antibody-mediated hemolysis.
Flegel WA
Transfusion; 2015 Jul; 55 Suppl 2(0):S47-58. PubMed ID: 26174897
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of A plasma for incompatible patients.
Olsen G; Passwater M; Huggins M; Mukhtar F; Pelletier P
Transfusion; 2021 Feb; 61(2):375-378. PubMed ID: 33219552
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
Mair B; Benson K
Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
[TBL] [Abstract][Full Text] [Related]
15. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma.
Berséus O; Boman K; Nessen SC; Westerberg LA
Transfusion; 2013 Jan; 53 Suppl 1():114S-123S. PubMed ID: 23301963
[TBL] [Abstract][Full Text] [Related]
16. Acute hemolysis of transfused A2 red cells by an auto-HI antibody.
Darabi K; Makar RS
Transfusion; 2008 May; 48(5):964-8. PubMed ID: 18454737
[TBL] [Abstract][Full Text] [Related]
17. Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.
Merle NS; Boudhabhay I; Leon J; Fremeaux-Bacchi V; Roumenina LT
Transfus Clin Biol; 2019 May; 26(2):116-124. PubMed ID: 30879901
[TBL] [Abstract][Full Text] [Related]
18. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
Irani MS; Karafin MS; Ernster L
J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
[TBL] [Abstract][Full Text] [Related]
19. White cell-associated procoagulant activity induced by ABO incompatibility.
Davenport RD; Polak TJ; Kunkel SL
Transfusion; 1994; 34(11):943-9. PubMed ID: 7974702
[TBL] [Abstract][Full Text] [Related]
20. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
